Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02493361
Title Trial of pIL-12/MK-3475 in Metastatic Melanoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Alain Algazi
Indications

melanoma

Therapies

Pembrolizumab

IL-12 gene

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of San Francisco, California San Francisco California 94115 United States Details
Huntsman Cancer Institute, University of Utah Salt Lake City Utah 84112 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field